BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28105982)

  • 1. Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion Through the Activation of iNOS in Lupus-Prone B6.MRL-
    Zhang Z; Feng R; Niu L; Huang S; Deng W; Shi B; Yao G; Chen W; Tang X; Gao X; Feng X; Sun L
    Cell Transplant; 2017 Jun; 26(6):1031-1042. PubMed ID: 28105982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice.
    Yang X; Yang J; Li X; Ma W; Zou H
    Lupus; 2018 Jan; 27(1):49-59. PubMed ID: 28537524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
    Cheng T; Ding S; Liu S; Li Y; Sun L
    Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No significant effects of Poly(I:C) on human umbilical cord-derived mesenchymal stem cells in the treatment of B6.MRL-Fas(lpr) mice.
    Huang S; Wang D; Gu F; Zhang Z; Deng W; Chen W; Tang X; Yao G; Feng X; Sun L
    Curr Res Transl Med; 2016; 64(2):55-60. PubMed ID: 27316386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells induced CD4+ T cell apoptosis in treatment of lupus mice.
    Huang S; Wu S; Zhang Z; Deng W; Fan J; Feng R; Kong W; Qi J; Chen W; Tang X; Yao G; Feng X; Wang D; Chen H; Sun L
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):30-35. PubMed ID: 30409422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase.
    Liu R; Su D; Zhou M; Feng X; Li X; Sun L
    Rheumatology (Oxford); 2015 Feb; 54(2):332-42. PubMed ID: 25169988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
    Zhang Z; Niu L; Tang X; Feng R; Yao G; Chen W; Li W; Feng X; Chen H; Sun L
    Nephrol Dial Transplant; 2019 Apr; 34(4):597-605. PubMed ID: 29982691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
    Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
    Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord derived mesenchymal stem cells promote interleukin-17 production from human peripheral blood mononuclear cells of healthy donors and systemic lupus erythematosus patients.
    Ren S; Hu J; Chen Y; Yuan T; Hu H; Li S
    Clin Exp Immunol; 2016 Mar; 183(3):389-96. PubMed ID: 26507122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.
    Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J
    Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li D; Li X; Duan M; Dou Y; Feng Y; Nan N; Zhang W
    Autoimmunity; 2020 Jun; 53(4):201-209. PubMed ID: 32321315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development.
    Jang E; Jeong M; Kim S; Jang K; Kang BK; Lee DY; Bae SC; Kim KS; Youn J
    Cell Transplant; 2016; 25(1):1-15. PubMed ID: 25975931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.
    Xu Y; Huang S; Ma K; Fu X; Han W; Sheng Z
    J Tissue Eng Regen Med; 2012 Aug; 6(8):645-54. PubMed ID: 21916019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
    Lin M; Huang L; Huang J; Yu J; Yang X; Yang J
    J Autoimmun; 2024 May; 145():103198. PubMed ID: 38428341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice.
    Mittereder N; Kuta E; Bhat G; Dacosta K; Cheng LI; Herbst R; Carlesso G
    J Immunol; 2016 Jul; 197(2):491-503. PubMed ID: 27296665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms.
    Lee HK; Kim HS; Kim JS; Kim YG; Park KH; Lee JH; Kim KH; Chang IY; Bae SC; Kim Y; Hong JT; Kehrl JH; Han SB
    Sci Rep; 2017 Jan; 7():41258. PubMed ID: 28117437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.